|   |   |
   Home  |  Site Map  |  Contact Us  

Over the next decade, nanotechnology has the potential to influence virtually every aspect of our lives, including our energy, food, water, buildings, and medicines. However, in order to realize this broad potential - robust, cost-effective, regulatory-friendly manufacturing technologies will be required. Through its novel technology platform and expansive intellectual property, Liquidia is poised to be a leader in the development of nanotechnology-based healthcare products and a catalyst for the growth anticipated across this industry.

By leveraging fabrication techniques from the semiconductor industry, Liquidia has the ability to rapidly design and manufacture precisely engineered particles of virtually any size, shape, or composition. Learn more >


September 30, 2015
Liquidia Technologies and GSK Advance Existing Collaboration; GSK Exercises Option for Inhaled Therapeutics Details

July 14, 2015
Liquidia Technologies names Robert A. Lippe Chief Operations Officer Details

April 8, 2015
Liquidia Technologies to Highlight Print® Technology at the World Vaccines Congress Details

October 3, 2014
Liquidia Technologies Highlights Its Transformative Print® Technology at the 12th International Nanomedicine and Drug Delivery Symposium Details


March 15, 2015
Liquidia highlighted as great example of innovation stemming from higher education Details

September 15, 2014
Xconomy: Raleigh-Durham Roundup: Liquidia, TrueBridge, Citrix, & More Details

September 10, 2014
TBJ: Durham's Liquidia spins out second company; raises $10M from Canaan Partners Details

May 22, 2014
Liquidia Technologies Featured at RTRP 2014 State of Region Event Details

March 3, 2014
TBJ: Liquidia Technologies a 2014 Health Care Hero Finalist Details

© 2015 Liquidia Technologies | PO Box 110085 | Research Triangle Park, NC 27709 | P.919.328.4400 | F.919.328.4402 | email: info@liquidia.com